PeptideStack
5.2kquestions
20kanswers
220users

Does headache at week six of dulaglutide usually resolve without a dose change?

Asked 19 Apr 2024Modified 2.3 years agoViewed 46k times
34

The case in front of me: headache · six · dulaglutide.

I am trying to do this correctly the first time rather than learn it by getting it wrong.

I have already made one mistake here that cost me a vial, so I am being deliberately careful.

What is the correct sequence, and where is the step that people usually skip?

gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

416 questionstitration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

444 questionsnausea
nausea

The dominant tolerability signal in every trial of the class: incidence, timing relative to a dose step, duration, and the distinction between…

346 questions
shareeditfollowflag
CM
askedcarys_meredith17k2819 Apr 2024
5Small correction: the units in the third paragraph should be micrograms, not milligrams. – esther_vandeVelde 6 months ago
4Do you have a reference for the last claim? Not disputing it, just want to read it. – Dr_Ilse_Vandenberg 4 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 46k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.